ALDOB is a prognostic biomarker and a potential immunotherapy target for clear cell renal cell carcinoma
Background Aldolase B (ALDOB), functioning as a glycolytic enzyme, exhibits a controversial role in malignancies and demonstrates dual potential as both a tumor suppressor and cancer-promoting enzyme. Nevertheless, it is still uncertain if there is a relationship between ALDOB levels, prognosis, and...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2025-08-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/19869.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|